Bernstein's double downgrade from a high-accuracy firm against a heavily bullish consensus creates a meaningful divergence signal, but the raised target and strong EPS revision momentum suggest the bearish view is nuanced, the stock's setup reflects tension between valuation concerns and improving fundamentals.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 17 $375.06entry
- T+1 · 2mo ago −3.06%α −2.94% · $363.58
- T+5 · 8w ago +3.96%α +3.28% · $389.92
- T+20 · 5w ago −1.28%α −2.48% · $370.27
- T+42 · todayOpen
- T+60 · in 24d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Bernstein double-downgraded Palo Alto Networks (PANW) from Outperform to Market Perform on September 17, 2026, while raising its price target from $253 to $351. The downgrade is a contrarian call against a heavily bullish consensus, 98% of analysts rate PANW a Buy or Strong Buy, with only one Sell. Bernstein's 71% accuracy on 7 PANW calls and average 5% return place it among top-tier firms covering the stock. The new $351 target sits well below the consensus mean of $393.42 and median of $410, implying 6.6% downside from the current $375.65 price. Momentum is mixed: zero upgrades in the past 30 days versus one downgrade, while EPS revisions for the current fiscal year show 37 upward revisions in the past week with no downward revisions. Insider selling has been heavy, five sales totaling over $2.1 million in the past month, including a $940,000 sale by Key John P. on September 14. Institutional activity is divergent: JPMorgan added 61.2% and FMR LLC doubled its stake, while Capital Research Global Investors trimmed 47.1%. The downgrade from a high-accuracy firm against a bullish consensus warrants attention, but the raised target and strong EPS revision momentum temper the bearish signal.
Impact Score
Consensus & Targets
Of 63 analysts covering PANW, 49 (78%) rate it Buy or Strong Buy, 13 (21%) Hold, and 1 (2%) Sell. The consensus is overwhelmingly bullish, making Bernstein's downgrade a clear contrarian call. The lone Sell rating stands in stark contrast to the 49 Buy-equivalent ratings.
The consensus mean price target is $393.42, median $410, high $475, and low $190. At $375.65, PANW trades 4.5% below the mean and 8.4% below the median. Bernstein's $351 target is 10.8% below the mean and 14.4% below the median, placing it in the lower quartile of analyst targets. The implied upside to Bernstein's target is 6.6% from current levels.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-17 | Bernstein | downgrade | Market Perform | $351.00 |
| 2026-09-03 | Argus Research | reiterate | Buy | $425.00 |
| 2026-09-02 | Citigroup | maintain | Buy | No target |
| 2026-09-02 | Roth Capital | maintain | Neutral | $300.00 |
| 2026-09-02 | Oppenheimer | maintain | Outperform | $450.00 |
| 2026-09-02 | Piper Sandler | reiterate | Overweight | $410.00 |
| 2026-09-02 | DA Davidson | maintain | Buy | $420.00 |
| 2026-09-02 | Barclays | maintain | Overweight | $375.00 |
| 2026-09-02 | RBC Capital | maintain | Outperform | $475.00 |
| 2026-09-02 | Guggenheim | reiterate | Neutral | No target |
Analyst activity in the past 30 days shows 0 upgrades and 1 downgrade (Bernstein). EPS revision momentum is strongly positive: 37 upward revisions for the current fiscal year in the past week with zero downward revisions, and 33 upward revisions for the current quarter. The 30-day trend shows 36 upward vs 10 downward revisions for the current year, indicating improving earnings expectations despite the downgrade.
Firm Track Record: Bernstein
Bernstein accuracy: 52% on 583 calls | avg return: 3.8%
Industry benchmark: mean 51% ± 10%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| HSBC | 100% | 3/3 | -1.6% | top tier |
| Stifel | 100% | 3/3 | 9.5% | top tier |
| Stephens & Co. | 100% | 2/2 | 12.7% | top tier |
| JP Morgan | 100% | 5/5 | 6.8% | top tier |
| Truist Securities | 80% | 4/5 | 7.3% | top tier |
| DA Davidson | 80% | 4/5 | 6.1% | top tier |
| Baird | 75% | 3/4 | 6.1% | top tier |
| Bernstein | 71% | 5/7 | 5% | top tier |
| Wedbush | 71% | 5/7 | 3.1% | top tier |
| RBC Capital | 71% | 5/7 | 4.8% | top tier |
Bernstein has a 71% accuracy rate on 7 PANW ratings with an average return of 5%, placing it among top-tier firms for this stock. This compares favorably to the broader analyst pool, the best-performing firms (HSBC, Stifel, Stephens & Co., JP Morgan) have 100% accuracy on small samples of 2-5 calls. Bernstein's track record gives this downgrade more weight than a low-accuracy firm's call.
Earnings Estimates
Next earnings: Nov 12, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1y | $2.21 | $1.32 to $3.03 | $16.2B | ↑4 ↓0 |
| 0y | $4.19 | $4.15 to $4.57 | $14.2B | ↑37 ↓0 |
| 0q | $0.97 | $0.95 to $1.01 | $3.3B | ↑33 ↓0 |
| +1q | $0.43 | $0.24 to $0.99 | $3.4B | ↑3 ↓0 |
Cross-Platform Signals
Insider trading shows significant selling: five transactions totaling over $2.1 million in the past month, including a $940,000 sale by Key John P. on September 14 and two sales by Bawa Aparna totaling $562,195 on September 14-15. These sales align with the bearish analyst signal. Congressional activity is mixed, one buy (Gottheimer, Democrat) and two sells (McGuire, Newhouse, Republicans) in small amounts. Institutional activity is divergent: JPMorgan added 61.2% and FMR LLC doubled its stake, while Capital Research Global Investors trimmed 47.1% and Optiver exited completely. Short interest stands at 58.6% of trading volume, indicating elevated bearish positioning.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
32 reports on PANW
5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +89.89% at T+60 after the Mar 27, 2026 report. 6 of 9 went positive at some point.
Filters
- Nov 10, 20267d ago PTAB Trial Neutral 2/10 Entry $326.36 Now $316.09 −3.15% settles Dec 9
- Nov 10, 20267d ago PTAB Trial Neutral 2/10 Entry $326.36 Now $316.09 −3.15% settles Dec 9
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $314.67 Now $316.09 +0.45% settles Dec 4
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $348.04 Now $316.09 −9.18% settles Dec 3
- Nov 2, 202614d ago 144 Neutral 3/10 Entry $350.20 Now $316.09 −9.74% settles Dec 2
- Oct 30, 202617d ago Press Release Neutral 2/10 Entry $365.87 Now $316.09 −13.61% settles Nov 30
- Oct 29, 202619d ago Court Ruling Bearish 4/10 Entry $365.87 Now $316.09 +13.61% settles Nov 30
- Oct 27, 202620d ago DEFA14A Neutral 3/10 Entry $394.49 Now $316.09 −19.87% settles Nov 25
- Oct 27, 202620d ago DEF 14A Neutral 4/10 Entry $394.49 Now $316.09 −19.87% settles Nov 25
- Oct 20, 202627d ago Institutional Cluster Bearish 4/10 Entry $347.25 Now $316.09 +8.97% settles Nov 18
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers